Dynavax Technologies Corp (NASDAQ: DVAX) kicked off on Tuesday, up 0.39% from the previous trading day, before settling in for the closing price of $12.85. Over the past 52 weeks, DVAX has traded in a range of $9.74-$15.01.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 239.63%. While this was happening, its average annual earnings per share was recorded 496.00%. With a float of $130.91 million, this company’s outstanding shares have now reached $131.34 million.
Considering the fact that the conglomerate employs 408 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 82.85%, operating margin of -3.42%, and the pretax margin is 9.29%.
Dynavax Technologies Corp (DVAX) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Drug Manufacturers – Specialty & Generic Industry. The insider ownership of Dynavax Technologies Corp is 0.42%, while institutional ownership is 103.79%. The most recent insider transaction that took place on May 31 ’24, was worth 43,127. In this transaction Director of this company sold 3,615 shares at a rate of $11.93, taking the stock ownership to the 36,905 shares. Before that another transaction happened on Mar 01 ’24, when Company’s Chief Accounting Officer sold 20,526 for $12.78, making the entire transaction worth $262,322. This insider now owns 0 shares in total.
Dynavax Technologies Corp (DVAX) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.03 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 496.00% per share during the next fiscal year.
Dynavax Technologies Corp (NASDAQ: DVAX) Trading Performance Indicators
Take a look at Dynavax Technologies Corp’s (DVAX) current performance indicators. Last quarter, stock had a quick ratio of 12.34. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.50. Likewise, its price to free cash flow for the trailing twelve months is 74.80.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.13, a number that is poised to hit 0.04 in the next quarter and is forecasted to reach 0.25 in one year’s time.
Technical Analysis of Dynavax Technologies Corp (DVAX)
Compared to the last year’s volume of 2.11 million, its volume of 1.43 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 49.21%. Additionally, its Average True Range was 0.36.
During the past 100 days, Dynavax Technologies Corp’s (DVAX) raw stochastic average was set at 76.14%, which indicates a significant increase from 48.57% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 14.54% in the past 14 days, which was lower than the 36.38% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $12.06, while its 200-day Moving Average is $11.60. Nevertheless, the first resistance level for the watch stands at $13.02 in the near term. At $13.15, the stock is likely to face the second major resistance level. The third major resistance level sits at $13.30. If the price goes on to break the first support level at $12.74, it is likely to go to the next support level at $12.59. Should the price break the second support level, the third support level stands at $12.46.
Dynavax Technologies Corp (NASDAQ: DVAX) Key Stats
The company with the Market Capitalisation of 1.70 billion has total of 131,455K Shares Outstanding. Its annual sales at the moment are 232,280 K in contrast with the sum of -6,390 K annual income. Company’s last quarter sales were recorded 80,630 K and last quarter income was 17,590 K.
